이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Early Nutrition and Heart Structure and Function in Preterm Infants During the First Year of Life

2026년 11월 4일 업데이트: Ahmed Elhady Ragaey Mahmoud, Assiut University

Study the Association of Early Nutritional Exposure With Cardiac Structure and Function in Preterm Infants During the First Year of Life: A Prospective Study

Preterm infants are babies born before 37 completed weeks of pregnancy. Early nutrition is important for their growth and development, and it may also be associated with how their heart develops and functions during infancy.

This prospective observational study aims to investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function at 12 months of corrected age in preterm infants. The study will be conducted at Assiut University Hospital and El-Eman General Hospital in Assiut, Egypt.

Preterm infants born before 37 weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate records of their nutritional intake, and whose parents provide written informed consent will be considered for participation. Infants with major congenital heart disease, known congenital cardiomyopathy, major genetic or chromosomal abnormalities, or other specified exclusion criteria will not be included.

The study will collect information about maternal and neonatal characteristics, neonatal complications, feeding patterns, growth, and anthropometric measurements. Cardiac structure and function will be assessed using echocardiography at birth, 6 months, and approximately 12 months of corrected age. Growth measurements will also be recorded at different time points, including 12 months of corrected age.

The study will compare cardiac measurements and growth outcomes among infants with different early nutritional exposures. It will also investigate which early nutritional and clinical factors are associated with left ventricular mass index at 12 months of corrected age.

The findings may improve understanding of the relationship between early nutrition and cardiovascular development in preterm infants. Participation will involve clinical data collection, growth measurements, and echocardiographic assessments, with written informed consent obtained from parents or legal guardians.

연구 개요

상태

아직 모집하지 않음

상세 설명

This prospective observational study will investigate the association between early nutritional exposure during the neonatal period and cardiac structure and function during the first year of life in preterm infants.

**Study Setting and Population**

The study will be conducted at the Department of Pediatric Medicine, Assiut University Hospital and El-Eman General Hospital, Assiut, Egypt. The study population will include preterm infants born before 37 completed weeks of gestation who are admitted to the neonatal unit within 24 hours of birth, have adequate nutritional records, and whose parents provide written informed consent. Infants must be available for follow-up echocardiographic assessment at 12 months of corrected age.

**Eligibility Criteria**

Infants with major congenital heart disease, known congenital cardiomyopathy, major chromosomal or genetic abnormalities, congenital anomalies, or infections associated with or potentially affecting cardiac disease will be excluded. Infants with inadequate nutritional records, those whose parents refuse written consent, and those without follow-up at one year will also be excluded.

**Nutritional Exposure Groups**

The protocol describes the following feeding groups:

  1. Preterm infants receiving early complementary feeding at 17 weeks.
  2. Preterm infants receiving late complementary feeding after 26 weeks.
  3. Preterm infants receiving breastfeeding.
  4. Preterm infants receiving artificial feeding.
  5. Preterm infants receiving both breast milk and artificial feeding.

Nutritional exposure will be evaluated in relation to cardiac and growth outcomes. The final operational definitions and classification of feeding groups will follow the study protocol.

**Data Collection**

Maternal information will include maternal age, parity, mode of conception, obstetric history and complications, antenatal corticosteroid and magnesium sulfate administration, and mode of delivery.

Neonatal information will include sex, gestational age, singleton or multiple birth, birth weight, length, head circumference, small-for-gestational-age, appropriate-for-gestational-age or large-for-gestational-age classification, Apgar scores, and resuscitation requirements. Neonatal complications will include respiratory distress syndrome, surfactant use, duration of ventilation, and length of hospital stay.

Anthropometric measurements, including weight, length, and head circumference, will be recorded at birth, 36 weeks of postmenstrual age, hospital discharge, and 12 months of corrected age. Appropriate growth z-scores will be calculated using relevant reference standards.

**Echocardiographic Assessment**

Echocardiography will be performed at birth, 6 months, and approximately 12 months of corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group.

Cardiac structural measurements will include left ventricular end-diastolic and end-systolic dimensions, septal and posterior wall thickness, left ventricular mass index, relative wall thickness, left ventricular sphericity index, left atrial size, right ventricular basal dimension, and aortic root dimensions.

Cardiac functional measurements will include left ventricular ejection fraction and global longitudinal strain; mitral E/A ratio, septal and lateral e', E/e' ratio, and isovolumetric relaxation time; tricuspid annular plane systolic excursion, tricuspid S', right ventricular fractional area change, right ventricular free-wall strain, pulmonary acceleration time, and septal configuration. Patent foramen ovale and patent ductus arteriosus, if identified, will be documented as incidental findings.

**Study Outcomes and Statistical Analysis**

The primary objective is to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.

Secondary objectives include comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups, and developing a predictive model to identify early nutritional and clinical factors associated with left ventricular mass index at 12 months.

Data will be analyzed using the Statistical Package for the Social Sciences (SPSS). Continuous variables will be summarized as mean ± standard deviation or median and interquartile range, as appropriate. Categorical variables will be presented as frequencies and percentages. Comparisons will use one-way analysis of variance or the Kruskal-Wallis test, with appropriate post hoc correction, and the chi-square test or Fisher's exact test for categorical variables. Multivariable linear regression will be used for the predictive model. A p-value below 0.05 will be considered statistically significant.

Written informed consent will be obtained from parents or legal guardians, and participant information will be handled confidentially by the research team.

연구 유형

관찰

등록 (추정된)

80

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

1년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Preterm infants at 1 year old age with past nutritional history avalible

설명

Inclusion Criteria:

  • Preterm infants born at <37 weeks of gestation.
  • preterm Infants admitted to the neonatal unit within 24 hours of birth.
  • preterm Infants who have adequate records of nutritional intake during the neonatal period.
  • Parents provided a consent for participation.
  • preterm Infants available for follow-up echocardiographic assessment at 12 months corrected age.

Exclusion Criteria:

  • preterm Infants with major congenital heart disease or known congenital cardiomyopathy.
  • preterm Infants with major chromosomal, genetic abnormalities, congenital anomaly, or infections associated with or have potential for cardiac disease.
  • Inadequate nutritional records.
  • Refusal to provide written consent.
  • Lack of follow-up at one year.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
개입 / 치료
- Group 1: Includes preterm Infants how receive early complementary feeding at 17 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 2: includes preterm infants how receive late complementary feeding After 26 weeks.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 3: includes preterm infants how receive breast feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
-Group 4: includes preterm infants who receive artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.
- Group 5: includes preterm infants who receive both breast and artificial feeding.

Echocardiography is performed at Birth , 6 months and after 12 months corrected age

Echocardiography is performed at Birth , 6 months and after 12 months corrected age (±2 weeks) by a single trained pediatric cardiologist blinded to the feeding group. The following parameters will be reported:

  • Cardiac structure: LV end-diastolic and end-systolic dimensions, septal and posterior wall thickness, LV mass index, relative wall thickness, LV sphericity index, left atrial size, RV basal dimension, and aortic root.
  • Cardiac function: LV ejection fraction, and global longitudinal strain; mitral E/A, septal and lateral e', E/e', and IVRT; TAPSE, tricuspid S', RV fractional area change, and RV free-wall strain; pulmonary acceleration time, and septal configuration. Note any PFO or PDA is incidental finding.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
기간
to investigate the association between early nutritional strategies and cardiac structure and function at 12 months of corrected age.
기간: one year old age of preterm infants
one year old age of preterm infants

2차 결과 측정

결과 측정
기간
comparing left ventricular mass index z-scores, other echocardiographic parameters, and anthropometric outcomes among feeding groups
기간: over one year period study
over one year period study

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 12월 1일

기본 완료 (추정된)

2027년 12월 1일

연구 완료 (추정된)

2027년 12월 30일

연구 등록 날짜

최초 제출

2026년 10월 17일

QC 기준을 충족하는 최초 제출

2026년 10월 17일

처음 게시됨 (실제)

2026년 10월 23일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 5일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 4일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다